Jose V Forero Forero
2PUBLICATIONS
14CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Feb 01, 2022
Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576.Januario E Castro, Paula A Lengerke-Diaz, Juliana Velez Lujan
Pageof 1
Frequent Collaborators
2 joint publications
Januario E Castro
2 joint publications
Paula A Lengerke-Diaz
2 joint publications
Eider F Moreno-Cortes
1 joint publications
Michael Y Choi
1 joint publications
Juan Esteban Garcia-Robledo
1 joint publications
Chaja Jacobs
1 joint publications
Thomas J Kipps
1 joint publications
Nanxi Yu
1 joint publications
Ryan M Porter
1 joint publications
Xinyu Zhou